Lyell Immunopharma, Inc. Other than Temporary Impairment Losses, Investments
Lyell Immunopharma, Inc. (LYEL) reported Other than Temporary Impairment Losses, Investments of $5.00 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Operating Expenses
us-gaap:ImpairmentOfInvestments · last filed 2022-11-08
- Lyell Immunopharma, Inc. other than temporary impairment losses, investments for the quarter ending 2022-09-30 was $5.00M.
- Lyell Immunopharma, Inc. other than temporary impairment losses, investments for the quarter ending 2021-12-31 was $36.45M.
- Lyell Immunopharma, Inc. other than temporary impairment losses, investments for the quarter ending 2021-09-30 was $0.00.
- Lyell Immunopharma, Inc. other than temporary impairment losses, investments for fiscal 2021 was $36.45M.
- Lyell Immunopharma, Inc. other than temporary impairment losses, investments for fiscal 2020 was $0.00.
- Lyell Immunopharma, Inc. other than temporary impairment losses, investments for fiscal 2019 was $0.00.
| Period end | Other than Temporary Impairment Losses, Investments 3 month | Other than Temporary Impairment Losses, Investments 6 month | Other than Temporary Impairment Losses, Investments 9 month | Other than Temporary Impairment Losses, Investments 12 month |
|---|---|---|---|---|
| 2022-09-30 | $5.00M 10-Q · filed 2022-11-08 | $5.00M 10-Q · filed 2022-11-08 | ||
| 2021-12-31 | $36.45M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $36.45M derived: sum of 2 quarters · filed 2022-11-08 | $36.45M 10-K · filed 2022-03-29 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | ||
| 2020-12-31 | $0.00 10-K · filed 2022-03-29 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |